• Je něco špatně v tomto záznamu ?

Signal transducer and activator of transcription 3 signaling in tumor immune evasion

L. Zhang, K. Kuca, L. You, Y. Zhao, K. Musilek, E. Nepovimova, Q. Wu, W. Wu, V. Adam

. 2022 ; 230 (-) : 107969. [pub] 20210824

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011217

The underlying mechanism of tumor immune evasion is a highly concerning subject for researchers. Increasing evidences reveal that the over-activated signal transducer and activator of transcription 3 (STAT3) is a crucial molecular hub in malignant tumors. STAT3 controls autophagy molecules that impair CTL-mediated tumor cell lysis, inhibiting natural killer cells and inducing apoptosis in T lymphocytes to create an immunosuppressive environment. STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to establish a tolerant tumor microenvironment (TME). STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to create an immunosuppressive environment. All this aid tumor cells in escaping from immune surveillance. In this review, we outlined the STAT3-mediated mechanisms involved in tumor immune evasion and their potential regulatory functions in the TME. We discussed the impact of STAT3 signaling on PD-L1, HIF-1α, exosome, lncRNA, and autophagy in the promotion of tumor immune evasion and highlighted the recent research on STAT3 signaling and tumor immune evasion that may assist in developing effective STAT3-targeted drugs for advancing immunotherapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011217
003      
CZ-PrNML
005      
20220506130326.0
007      
ta
008      
220425s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.pharmthera.2021.107969 $2 doi
035    __
$a (PubMed)34450232
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Zhang, Luying $u College of Life Science, Yangtze University, Jingzhou 434025, China
245    10
$a Signal transducer and activator of transcription 3 signaling in tumor immune evasion / $c L. Zhang, K. Kuca, L. You, Y. Zhao, K. Musilek, E. Nepovimova, Q. Wu, W. Wu, V. Adam
520    9_
$a The underlying mechanism of tumor immune evasion is a highly concerning subject for researchers. Increasing evidences reveal that the over-activated signal transducer and activator of transcription 3 (STAT3) is a crucial molecular hub in malignant tumors. STAT3 controls autophagy molecules that impair CTL-mediated tumor cell lysis, inhibiting natural killer cells and inducing apoptosis in T lymphocytes to create an immunosuppressive environment. STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to establish a tolerant tumor microenvironment (TME). STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to create an immunosuppressive environment. All this aid tumor cells in escaping from immune surveillance. In this review, we outlined the STAT3-mediated mechanisms involved in tumor immune evasion and their potential regulatory functions in the TME. We discussed the impact of STAT3 signaling on PD-L1, HIF-1α, exosome, lncRNA, and autophagy in the promotion of tumor immune evasion and highlighted the recent research on STAT3 signaling and tumor immune evasion that may assist in developing effective STAT3-targeted drugs for advancing immunotherapy.
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a lidé $7 D006801
650    12
$a transkripční faktor STAT3 $x metabolismus $7 D050796
650    _2
$a signální transdukce $7 D015398
650    12
$a únik nádoru z imunitní kontroly $7 D019139
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic
700    1_
$a You, Li $u College of Life Science, Yangtze University, Jingzhou 434025, China
700    1_
$a Zhao, Yingying $u College of Life Science, Yangtze University, Jingzhou 434025, China
700    1_
$a Musilek, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic
700    1_
$a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic
700    1_
$a Wu, Qinghua $u College of Life Science, Yangtze University, Jingzhou 434025, China; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic. Electronic address: wqh212@hotmail.com
700    1_
$a Wu, Wenda $u MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic. Electronic address: wuwenda@njau.edu.cn
700    1_
$a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno 613 00, Czech Republic; Central European Institute of Technology, Brno University of Technology, Brno 602 00, Czech Republic. Electronic address: vojtech.adam@mendelu.cz
773    0_
$w MED00006662 $t Pharmacology & therapeutics $x 1879-016X $g Roč. 230, č. - (2022), s. 107969
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34450232 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130318 $b ABA008
999    __
$a ok $b bmc $g 1789028 $s 1162415
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 230 $c - $d 107969 $e 20210824 $i 1879-016X $m Pharmacology & therapeutics $n Pharmacol Ther $x MED00006662
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...